SecBot SecBot
SECBOTREPLAY Home › Report › INSP

INSP · Inspire Medical Systems reported Q3 2026 revenue of $206.7M, down 7.9%…

Inspire Medical Systems · PRESS-RELEASE filed Nov 2, 2026 at 16:28 ET

At the news

NEUTRALIMPACT 5/10

PRESS-RELEASE filed Nov 2, 2026 at 16:28 ET

Inspire Medical Systems reported Q3 2026 revenue of $206.7M, down 7.9% YoY, and adjusted diluted EPS of $0.14, beating the consensus estimate of $0.09. The company narrowed its full-year 2026 revenue guidance to $850M-$860M (from $835M-$875M) and maintained adjusted EPS guidance of $1.20-$1.40. Revenue decline was driven by coding and reimbursement headwinds, partially offset by higher-margin Inspire V mix and a new CPT code approval for 2028.

  • Q3 2026 revenue $206.7M, down 7.9% YoY from $224.5M
  • GAAP diluted EPS $(0.84); adjusted diluted EPS $0.14 (consensus $0.09, beat)
  • Operating loss $(28.7M); adjusted operating income $1.9M (0.9% margin)
  • Net loss $(24.4M) vs net earnings $9.9M in Q3 2025

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access